PI3K-beta inhibitors (Takeda Pharmaceuticals)

N/A

Report date: 2025/01/26 15:47:04
NME

Base Information

Drug NamePI3K-beta inhibitors (Takeda Pharmaceuticals)
Drug Alias NameA-10-M
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase beta inhibitors
TargetsPhosphatidylinositol 3 kinase beta
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceuticals International, Inc
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceuticals International, Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A